
HF Foods implements short-term rights plan to counter unsolicited share accumulation
HF Foods Group (NASDAQ:HFFG) announced that its Board of Directors has adopted a limited-duration stockholder rights plan, commonly known as a "poison pill," intended to protect corporate assets against potential hostile takeover attempts.
The defensive mechanism was established after the board identified indications that outside entities may be engaging in undisclosed open-market stock accumulation and coordinated group formation to acquire control of the business.
Under the terms of the newly enacted plan, the company will distribute a dividend of one right for each outstanding share of common stock held by stockholders of record as of the close of business on June 22, 2026.
The rights plan features a 15% beneficial ownership trigger threshold.
If any single entity or coordinated investment group crosses this line without prior board approval, the rights will become exercisable, allowing all other existing shareholders to purchase additional common stock at a discounted rate, thereby diluting the acquiring party's stake.
The strategy is scheduled to run for a 364-day duration, expiring on June 10, 2027.
Management noted that the plan has not been put in place to block a corporate sale, but rather to maximize bargaining leverage and give the board adequate timeline to evaluate incoming investment proposals.
The Las Vegas-based specialty food distributor—which services Asian restaurants nationwide—recently completed major supply chain and ERP technology rollouts, and board members reiterated that the standalone operational plan remains the optimal path toward maximizing long-term shareholder equity.
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue